233 related articles for article (PubMed ID: 2483446)
1. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
[TBL] [Abstract][Full Text] [Related]
2. The long-term efficacy of ibopamine in treating patients with severe heart failure: a multicenter investigation.
Condorelli M; Bonaduce A; Montemurro A; Mattioli G; Cappello C; Caponnetto S; Terrachini V; Canale C; Varricchio M; Cacciapuoti F
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S83-92. PubMed ID: 2483445
[TBL] [Abstract][Full Text] [Related]
3. [Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].
Fonseca C; Gouveia R; Ceia F; Mota E; Coelho EM; Gil V; Riva E; Astorga MA; Gomes RS; Luís AS
Rev Port Cardiol; 1992 Jun; 11(6):515-23. PubMed ID: 1503784
[TBL] [Abstract][Full Text] [Related]
4. Ibopamine: long-term safety study in patients with congestive heart failure. The Italian Ibopamine Working Group.
Riva E; Cavalli A; Abbondati G; Cedrini MC; Schleman M; Fuccella LM
Int J Clin Pharmacol Res; 1989; 9(1):21-8. PubMed ID: 2707922
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of ibopamine in long-term treatment of dilated cardiomyopathy. A clinical and instrumental evaluation.
Benassi A; Modena MG; Mattioli G
Arzneimittelforschung; 1986 Feb; 36(2A):390-4. PubMed ID: 3518726
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
Dei Cas L; Metra M; Nodari S; Visioli O
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
[TBL] [Abstract][Full Text] [Related]
7. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
[TBL] [Abstract][Full Text] [Related]
8. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
[TBL] [Abstract][Full Text] [Related]
9. Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
Caponnetto S; Terrachini V; Canale C; Bruzzone F; Licciardello L; Marchetti GV
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S104-10. PubMed ID: 2483435
[TBL] [Abstract][Full Text] [Related]
10. Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
Sher D; Licciardello L; Ferrari V; Sirtori F; Cesana B
Arzneimittelforschung; 1991 Apr; 41(4):402-9. PubMed ID: 1859514
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
Sannia L; Ibba GV; Castellaccio M; Dore L
Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
[TBL] [Abstract][Full Text] [Related]
12. Multicenter study on the clinical efficacy of chronic ibopamine administration.
Dei Cas L; Barilli AC; Metra M; Fracalossi C; Lomanto B; Santambrogio S; Pinca L; Longhini C; Cavicchi E; Maggi GC
Arzneimittelforschung; 1986 Feb; 36(2A):383-5. PubMed ID: 3707655
[TBL] [Abstract][Full Text] [Related]
13. A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
Ferrari V; Sher D; Marchetti G
Arzneimittelforschung; 1986 Feb; 36(2A):398-405. PubMed ID: 3707657
[TBL] [Abstract][Full Text] [Related]
14. Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
Di Mario C; Compostella L; Iavernaro A; Libardoni M; Ghirardi P; Cucchini F
Arzneimittelforschung; 1990 Jun; 40(6):661-6. PubMed ID: 2397001
[TBL] [Abstract][Full Text] [Related]
15. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S77-82. PubMed ID: 2483444
[TBL] [Abstract][Full Text] [Related]
16. Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation.
Caponnetto S; Allegro A; Bellotti G; Cataldi A; Salvemini M; Portioli I; Prati PL; Gambelli G; Boccanelli A; Zacharo E
Arzneimittelforschung; 1986 Feb; 36(2A):386-90. PubMed ID: 3518725
[TBL] [Abstract][Full Text] [Related]
17. [Ibopamine--clinical results].
Kleber FX
Z Kardiol; 1991; 80 Suppl 8():71-6. PubMed ID: 1686695
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapeutic profile of ibopamine in heart failure.
Taylor SH
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
Humar F; Morgera T; Maras P; Camerini F
Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
[TBL] [Abstract][Full Text] [Related]
20. Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
Cadel A; Brusoni B; Pirelli P; Osculati G; Rovati A; Fanciulli R; Carati L; Valagussa F
Arzneimittelforschung; 1986 Feb; 36(2A):376-9. PubMed ID: 3707653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
